How to invest in Zomedication, the generic drugmaker, if you want to get in on the lucrative drug business.
If you’re looking for ways to invest this week, check out our article on stock investing in ZMedica Pharmaceutical.
If it seems too good to be true, it probably is.
ZMedication is the brand name for a drugmaker that makes generic versions of some of the most popular prescription drugs in the world.
They’re made by Pfizer, Bristol-Myers Squibb, Johnson & Johnson, AstraZeneca, and AbbVie.ZMedication’s stock price surged over the weekend, jumping from $10.40 to $22.50 after it raised $1.5 billion in new funding.
That’s more than double what it was at the start of the week, but the stock’s gain isn’t nearly as dramatic as its price growth.
The company’s stock has climbed more than 25% in the past two weeks.
Its stock has risen so much that it’s more valuable than the S&P 500 index, according to FactSet.
The S&s is the benchmark for US stocks and the index has climbed almost 20% since the beginning of the year.
The stock price has soared in recent weeks because of the company’s blockbuster drug-approval campaign, which includes raising the price of some drugs by up to 60% from their original retail price.
The campaign, launched in the wake of a deadly coronavirus pandemic in 2015, has helped the company increase its sales and profits.
In August, ZMedications CEO Andrew Zobel said the company has made more than $3 billion in the first nine months of the drug-adoption program.